Sign in
4

Changes in Ownership

NEKTAR THERAPEUTICS Filed Acc 0001209191-20-051388

Director sold 2,250 shares at $19.74 ($44,415)

From the SEC's structured data for this filing

Trades in this filing

Ajer Jeffrey Robert · Director

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2020-09-21 Sale : show line 1 in the form −2,250 $19.74 $44,415 20,125 D
Open-market sales · 2,250 sh · avg $19.74 · $44,415
Loading xslF345X03/doc4.xml…